Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy.

[1]  D. Glaze,et al.  Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched control study. , 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[2]  D. J. Driscoll,et al.  Elevated plasma oxytocin levels in children with Prader–Willi syndrome compared with healthy unrelated siblings , 2016, American journal of medical genetics. Part A.

[3]  M. Butler,et al.  Original article Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study , 2016 .

[4]  M. Coupaye,et al.  Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi Syndrome: a matched control study. , 2016, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[5]  O. Ilkayeva,et al.  Metabolic profiling in Prader–Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone , 2015, Clinical endocrinology.

[6]  V. Gross‐Tsur,et al.  Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade. , 2015, Human reproduction.

[7]  D. Broadhurst,et al.  Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome. , 2015, The Journal of clinical endocrinology and metabolism.

[8]  K. Steinbeck,et al.  Postprandial metabolism in adults with prader–willi syndrome , 2015, Obesity.

[9]  C. Höybye.  Growth hormone treatment of Prader–Willi syndrome has long‐term, positive effects on body composition , 2015, Acta paediatrica.

[10]  K. Clément,et al.  Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity. , 2015, The Journal of clinical endocrinology and metabolism.

[11]  A. Haqq,et al.  Hormonal and metabolic responses to endurance exercise in children with Prader-Willi syndrome and non-syndromic obesity. , 2015, Metabolism: clinical and experimental.

[12]  J. Rotteveel,et al.  Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment. , 2015, The Journal of clinical endocrinology and metabolism.

[13]  S. Adami,et al.  Adults with Prader–Willi Syndrome have Weaker Bones: Effect of Treatment with GH and Sex Steroids , 2015, Calcified Tissue International.

[14]  Daniel J Driscoll,et al.  Growth Charts for Non-Growth Hormone Treated Prader-Willi Syndrome , 2015, Pediatrics.

[15]  A. Hokken-Koelega,et al.  Behavior in children with Prader–Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study , 2015, European Child & Adolescent Psychiatry.

[16]  J. Tucker,et al.  Patterns of habitual physical activity in youth with and without Prader-Willi Syndrome. , 2014, Research in developmental disabilities.

[17]  A. Guastella,et al.  A double‐blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome , 2014, American journal of medical genetics. Part A.

[18]  A. Holland,et al.  Ageing in people with Prader–Willi syndrome: mortality in the UK population cohort and morbidity in an older sample of adults , 2014, Psychological Medicine.

[19]  J. Hamilton,et al.  Clinically Important Age-Related Differences in Sleep Related Disordered Breathing in Infants and Children with Prader-Willi Syndrome , 2014, PloS one.

[20]  Z. Aycan,et al.  Prader-Willi Syndrome and Growth Hormone Deficiency , 2014, Journal of clinical research in pediatric endocrinology.

[21]  N. Dhanesha,et al.  Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity , 2014, Diabetes, metabolic syndrome and obesity : targets and therapy.

[22]  Jennifer L Miller,et al.  An open‐label pilot study of N‐acetylcysteine for skin‐picking in Prader–Willi syndrome , 2014, American journal of medical genetics. Part A.

[23]  F. Benarroch,et al.  Management of hypogonadism in adolescent girls and adult women with Prader–Willi syndrome , 2013, American journal of medical genetics. Part A.

[24]  J. Rotteveel,et al.  Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. , 2013, The Journal of clinical endocrinology and metabolism.

[25]  K. Clément,et al.  Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity , 2013, International Journal of Obesity.

[26]  J. Emerick,et al.  Endocrine manifestations and management of Prader-Willi syndrome , 2013, International Journal of Pediatric Endocrinology.

[27]  H. Herzog,et al.  Mouse models of Prader–Willi Syndrome: A systematic review , 2013, Frontiers in Neuroendocrinology.

[28]  John J. Kopchick,et al.  Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome , 2013, The Journal of clinical endocrinology and metabolism.

[29]  S. Ito,et al.  The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome. , 2012, Endocrine journal.

[30]  D. Barbara,et al.  Intraoperative Adrenal Insufficiency in a Patient with Prader-Willi Syndrome , 2012, Journal of clinical medicine research.

[31]  S. Wong,et al.  Ghrelin Level and Weight Loss After Laparoscopic Sleeve Gastrectomy and Gastric Mini-Bypass for Prader–Willi Syndrome in Chinese , 2012, Obesity Surgery.

[32]  A. Markou,et al.  N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking , 2012, Psychopharmacology.

[33]  J. Laven,et al.  Ovarian function and reproductive hormone levels in girls with Prader-Willi syndrome: a longitudinal study. , 2012, The Journal of clinical endocrinology and metabolism.

[34]  A. Salvatoni,et al.  Assessment of central adrenal insufficiency in children and adolescents with Prader–Willi syndrome , 2012, Clinical endocrinology.

[35]  M. Sinnema,et al.  Aging in Prader–Willi syndrome: Twelve persons over the age of 50 years , 2012, American journal of medical genetics. Part A.

[36]  J. Rotteveel,et al.  Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. , 2012, The Journal of clinical endocrinology and metabolism.

[37]  J. Whittington,et al.  Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome , 2012, International Journal of Obesity.

[38]  D. J. Driscoll,et al.  Prader-Willi syndrome. , 1984, Current problems in pediatrics.

[39]  J. Frystyk,et al.  Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome. , 2012, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[40]  F. de Jong,et al.  Pubarche and serum dehydroepiandrosterone sulphate levels in children with Prader–Willi syndrome , 2011, Clinical endocrinology.

[41]  M. Tauber,et al.  Efficacy of modafinil on excessive daytime sleepiness in Prader–Willi syndrome , 2011, American journal of medical genetics. Part A.

[42]  C. Mantoulan,et al.  Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients , 2011, Orphanet journal of rare diseases.

[43]  K. Hoffman.  Animal models of obsessive compulsive disorder: recent findings and future directions , 2011, Expert opinion on drug discovery.

[44]  K. Steinbeck,et al.  Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome. , 2011, The Journal of clinical endocrinology and metabolism.

[45]  D. C. Driscoll,et al.  Nutritional phases in Prader–Willi syndrome , 2011, American journal of medical genetics. Part A.

[46]  N. Katsilambros,et al.  Meal-induced thermogenesis and macronutrient oxidation in lean and obese women after consumption of carbohydrate-rich and fat-rich meals. , 2011, Nutrition.

[47]  D. J. Driscoll,et al.  Carnitine and coenzyme Q10 levels in individuals with Prader–Willi syndrome , 2011, American journal of medical genetics. Part A.

[48]  S. Grambow,et al.  The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. , 2010, The Journal of clinical endocrinology and metabolism.

[49]  M. Tauber,et al.  Endocrine Disorders in Children with Prader-Willi Syndrome – Data from 142 Children of the French Database , 2010, Hormone Research in Paediatrics.

[50]  K. Cianflone,et al.  Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment. , 2010, The Journal of clinical endocrinology and metabolism.

[51]  Health Supervision for Children With Prader-Willi Syndrome , 2016, Pediatric Clinical Practice Guidelines & Policies.

[52]  H. Duivenvoorden,et al.  Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome. , 2009, The Journal of clinical endocrinology and metabolism.

[53]  R. Wevrick,et al.  Necdin, a Prader-Willi syndrome candidate gene, regulates gonadotropin-releasing hormone neurons during development. , 2008, Human molecular genetics.

[54]  P. Navas,et al.  Coenzyme Q10 deficiencies in neuromuscular diseases. , 2009, Advances in experimental medicine and biology.

[55]  S. Grambow,et al.  Ghrelin concentrations in Prader–Willi syndrome (PWS) infants and children: changes during development , 2008, Clinical endocrinology.

[56]  M. Tauber,et al.  Recommendations for the diagnosis and management of Prader-Willi syndrome. , 2008, The Journal of clinical endocrinology and metabolism.

[57]  H. Duivenvoorden,et al.  Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader–Willi syndrome , 2008, Clinical endocrinology.

[58]  V. Rousson,et al.  Developmental profiles in young children with Prader–Labhart–Willi syndrome: Effects of weight and therapy with growth hormone or coenzyme Q10 , 2008, American journal of medical genetics. Part A.

[59]  U. Francke,et al.  SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice , 2008, PloS one.

[60]  C. Cuffari,et al.  Critical Analysis of Bariatric Procedures in Prader-Willi Syndrome , 2008, Journal of pediatric gastroenterology and nutrition.

[61]  S. Grambow,et al.  Altered distribution of adiponectin isoforms in children with Prader–Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones , 2007, Clinical endocrinology.

[62]  C. Stewart,et al.  Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome. , 2007, Human molecular genetics.

[63]  L. Reddy,et al.  Behavioral and Emotional Symptoms of Children and Adolescents with Prader-Willi Syndrome , 2007, Journal of autism and developmental disorders.

[64]  M. Butler.  Management of obesity in Prader–Willi syndrome , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[65]  D. Cummings,et al.  Ghrelin levels in young children with Prader-Willi syndrome. , 2006, The Journal of pediatrics.

[66]  D. Swaab,et al.  The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome. , 2005, The Journal of clinical endocrinology and metabolism.

[67]  N. Niikawa,et al.  Cause of sudden, unexpected death of Prader–Willi syndrome patients with or without growth hormone treatment , 2005, American journal of medical genetics. Part A.

[68]  M. Sacco,et al.  Sudden Death in Prader-Willi Syndrome during Growth Hormone Therapy , 2005, Hormone Research in Paediatrics.

[69]  E. Mignot,et al.  Hypocretin deficiency in Prader–Willi syndrome , 2005, European journal of neurology.

[70]  Z. Talebizadeh,et al.  Insulin resistance and obesity‐related factors in Prader–Willi syndrome: Comparison with obese subjects , 2004, Clinical genetics.

[71]  K. Devriendt,et al.  Minimum prevalence, birth incidence and cause of death for Prader–Willi syndrome in Flanders , 2004, European Journal of Human Genetics.

[72]  J. Fryns,et al.  Prader–Willi syndrome: Causes of death in an international series of 27 cases , 2004, American journal of medical genetics. Part A.

[73]  E. Zackai,et al.  Unexpected death and critical illness in Prader–Willi syndrome: Report of ten individuals , 2004, American journal of medical genetics. Part A.

[74]  A. Bondy,et al.  Behavioral treatment of obesity in patients with Prader-Willi syndrome , 1978, Journal of Behavioral Medicine.

[75]  C. Deal,et al.  Sudden death in growth hormone-treated children with Prader-Willi syndrome. , 2004, The Journal of pediatrics.

[76]  T. Shriver,et al.  Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. , 2003, The Journal of pediatrics.

[77]  S. Dimauro,et al.  Coenzyme Q10 levels in Prader‐Willi syndrome: Comparison with obese and non‐obese subjects , 2003, American journal of medical genetics. Part A.

[78]  A. Haqq,et al.  Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. , 2003, The Journal of clinical endocrinology and metabolism.

[79]  E. Dykens,et al.  Psychiatric Disorders in Prader-Willi Syndrome , 2003, CNS drugs.

[80]  Y. Nordmann,et al.  Sudden Death of an Infant with Prader-Willi Syndrome – Not a Unique Case? , 2002, Neonatology.

[81]  Y. Nordmann,et al.  Fatal Outcome of Sleep Apnoea in PWS during the Initial Phase of Growth Hormone Treatment , 2002, Hormone Research in Paediatrics.

[82]  M. Schwartz,et al.  Elevated plasma ghrelin levels in Prader–Willi syndrome , 2002, Nature Medicine.

[83]  A. Holland,et al.  Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. , 2002, Developmental medicine and child neurology.

[84]  D. Allen,et al.  Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. , 2002, The Journal of clinical endocrinology and metabolism.

[85]  Jimmy D Bell,et al.  Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. , 2002, The American journal of clinical nutrition.

[86]  D. Allen,et al.  The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study. , 2002, Pediatrics.

[87]  K. Õunap,et al.  Sudden death of a girl with Prader-Willi syndrome. , 2002, Genetic counseling.

[88]  P. Burman,et al.  Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. , 2001, Endocrine reviews.

[89]  S. Schwartz,et al.  The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. , 2001, Pediatrics.

[90]  D. Allen,et al.  Sustained Benefits of Growth Hormone on Body Composition, Fat Utilization, Physical Strength and Agility, and Growth in Prader-Willi Syndrome are Dose-Dependent , 2001, Journal of pediatric endocrinology & metabolism : JPEM.

[91]  G. Grugni,et al.  Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome , 2001, Journal of endocrinological investigation.

[92]  R. Biancheri,et al.  Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors , 2001, Clinical Neurophysiology.

[93]  K. Brøndum‐Nielsen,et al.  Fertility in Prader‐Willi syndrome: a case report with Angelman syndrome in the offspring , 2001, Acta paediatrica.

[94]  Y. Schutz,et al.  Meal-induced thermogenesis and obesity: is a fat meal a risk factor for fat gain in children? , 2001, The Journal of clinical endocrinology and metabolism.

[95]  U. Eiholzer,et al.  Growth Hormone Normalises Height, Prediction of Final Height and Hand Length in Children with Prader-Willi Syndrome after 4 Years of Therapy , 2000, Hormone Research in Paediatrics.

[96]  D. Allen,et al.  Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. , 2000, The Journal of pediatrics.

[97]  C. Williams,et al.  Prader-Willi and Angelman syndromes: sister imprinted disorders. , 2000, American journal of medical genetics.

[98]  K. Westerterp,et al.  Energy expenditure at rest and during sleep in children with Prader-Willi syndrome is explained by body composition. , 2000, The American journal of clinical nutrition.

[99]  A. Salvatoni,et al.  GH/IGF-I axis in Prader-Willi syndrome: Evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli , 2000, Journal of endocrinological investigation.

[100]  E. Ritzén,et al.  Five years of growth hormone treatment in children with Prader‐Willi syndrome , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[101]  C. Gillberg,et al.  ‘A woman with Prader‐Willi syndrome gives birth to a healthy baby girl’ , 1999, Developmental medicine and child neurology.

[102]  M. Sun,et al.  Development and validation of a measurement system for assessment of energy expenditure and physical activity in Prader-Willi syndrome. , 1999, Obesity research.

[103]  L. Molinari,et al.  Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome. , 1999, The Journal of pediatrics.

[104]  D. Allen,et al.  Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study. , 1999, The Journal of pediatrics.

[105]  J. Milerad,et al.  Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. , 1999, European journal of pediatrics.

[106]  L. Molinari,et al.  Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome , 1998, European Journal of Pediatrics.

[107]  M. B. Ranke,et al.  Reference values for height and weight in Prader-Willi syndrome based on 315 patients , 1998, European Journal of Pediatrics.

[108]  S. Buoni,et al.  Growth hormone secretion in Prader-Willi syndrome , 1998, Journal of endocrinological investigation.

[109]  Morabito,et al.  Reduced growth hormone (GH) responsiveness to combined GH‐releasing hormone and pyridostigmine administration in the Prader–Willi syndrome , 1998, Clinical endocrinology.

[110]  N. B. Johnson,et al.  Growth Failure in Prader-Willi Syndrome Is Secondary to Growth Hormone Deficiency , 1998, Hormone Research in Paediatrics.

[111]  T. Brismar,et al.  Growth hormone treatment of children with Prader‐Willi syndrome affects linear growth and body composition favourably , 1998, Acta paediatrica.

[112]  J. Fryns,et al.  Sudden death in children with Prader-Willy syndrome: a call for collaboration. , 1998, Genetic counseling.

[113]  P. Brambilla,et al.  Peculiar body composition in patients with Prader-Labhart-Willi syndrome. , 1997, The American journal of clinical nutrition.

[114]  D. Schuster,et al.  Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. , 1996, Metabolism: clinical and experimental.

[115]  M. Sarrantonio,et al.  Growth Hormone Secretion and Effects of Growth Hormone Therapy on Growth Velocity and Weight Gain in Children with Prader-Willi Syndrome , 1996, Journal of pediatric endocrinology & metabolism : JPEM.

[116]  D. Gozal,et al.  Hypoxic and hypercapnic ventilatory responses in Prader-Willi syndrome. , 1994, Journal of applied physiology.

[117]  E. Hollander,et al.  A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome. , 1994, The Journal of neuropsychiatry and clinical neurosciences.

[118]  P. Davies,et al.  Using stable isotopes to assess reduced physical activity of individuals with Prader-Willi syndrome. , 1993, American journal of mental retardation : AJMR.

[119]  K. Silverthorn,et al.  Beneficial effects of exercise on aerobic capacity and body composition in adults with Prader-Willi syndrome. , 1993, American journal of mental retardation : AJMR.

[120]  M. Butler,et al.  Prader-Willi syndrome: consensus diagnostic criteria. , 1993, Pediatrics.

[121]  E. Ghigo,et al.  Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome. , 1993, Hormone research.

[122]  P. Pipes,et al.  A nutrition survey of and recommendations for individuals with Prader-Willi syndrome who live in group homes. , 1992, Journal of the American Dietetic Association.

[123]  W. Walker,et al.  Parenteral protein-sparing modified fast in an obese adolescent with Prader-Willi syndrome. , 2009, Nutrition reviews.

[124]  M. Butler,et al.  Standards for selected anthropometric measurements in Prader-Willi syndrome. , 1991, Pediatrics.

[125]  H. Berthoud,et al.  Morphology and distribution of efferent vagal innervation of rat pancreas as revealed with anterograde transport of Dil , 1991, Brain Research.

[126]  V. A. Holm,et al.  Growth Hormone Secretion in Prader‐Willi Syndrome , 1990, Acta paediatrica Scandinavica.

[127]  K. Segal,et al.  Thermic effect of a meal over 3 and 6 hours in lean and obese men. , 1990, Metabolism: clinical and experimental.

[128]  E. Ravussin,et al.  Energy expenditure in humans: effects of dietary fat and carbohydrate. , 1990, The American journal of physiology.

[129]  M. Polansky,et al.  Thermic effect of food in lean and obese men. , 1988, The Journal of clinical investigation.

[130]  L. Greenswag,et al.  ADULTS WITH PRADER‐WILLI SYNDROME: A SURVEY OF 232 CASES , 1987 .

[131]  R. Noack,et al.  Diet-induced thermogenesis in man: thermic effects of single protein and carbohydrate test meals in lean and obese subjects. , 1987, Annals of nutrition & metabolism.

[132]  E. Jéquier,et al.  New evidence for a thermogenic defect in human obesity. , 1985, International journal of obesity.

[133]  C. Lutton,et al.  Cholesterol metabolism in lean and obese Zucker rats: effects of portacaval anastomosis. , 1985, International journal of obesity.

[134]  Y. Schutz,et al.  Diet-induced thermogenesis measured over a whole day in obese and nonobese women. , 1984, The American journal of clinical nutrition.

[135]  D. Schoeller,et al.  ENERGY EXPENDITURE AND BODY COMPOSITION IN PRADER-WILLI SYNDROME , 1984, Pediatric Research.

[136]  R. Taylor,et al.  A clinical note on food preference of individuals with Prader-Willi syndrome: the need for empirical research. , 2008, Journal of mental deficiency research.

[137]  S. Sulzbacher,et al.  Activity levels of persons with Prader-Willi syndrome. , 1983, American journal of mental deficiency.

[138]  G. Bray,et al.  The Prader‐Willi Syndrome: A Study of 40 Patients and a Review of the Literature , 1983, Medicine.

[139]  J. Kriz,et al.  Management of a patient with Prader-Willi syndrome by a dental-dietary team. , 1981, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[140]  Heiman Mf.  The management of obesity in the post-adolescent developmentally disabled client with Prader-Willi syndrome. , 1978 .

[141]  M. Heiman.  The management of obesity in the post-adolescent developmentally disabled client with Prader-Willi syndrome. , 1978, Adolescence.

[142]  V. A. Holm,et al.  Management of Prader-Willi Syndrome , 1977, The Journal of pediatrics.

[143]  G. Blackburn,et al.  Metabolic aspects of a protein-sparing modified fast in the dietary management of Prader-Willi obesity. , 1977, The New England journal of medicine.

[144]  V. A. Holm,et al.  Food and children with Prader-Willi syndrome. , 1976, American journal of diseases of children.

[145]  A. Gormican,et al.  Out-patient dietary management in the Prader-Willi syndrome. , 1976, Journal of the American Dietetic Association.

[146]  R. Ruvalcaba,et al.  Some aspects of carbohydrate metabolism in Prader-Willi syndrome. , 2008, Journal of mental deficiency research.

[147]  Pipes Pl,et al.  Weight control of children with Prader-Willi syndrome. , 1973 .

[148]  V. A. Holm,et al.  Weight control of children with Prader-Willi syndrome. , 1973, Journal of the American Dietetic Association.

[149]  J. Jancar.  Prader-Willi syndrome. (Hypotonia, obesity, hypogonadism, growth and mental retardation). , 2010, Journal of mental deficiency research.

[150]  Evans Pr.  HYPOGENITAL DYSTROPHY WITH DIABETIC TENDENCY. , 1964 .